AstraZeneca to cut 2,300 jobs in business overhaul
(AP)—Struggling drug company AstraZeneca outlined a major restructuring of its business on Thursday, including some 2,300 job cuts worldwide as it overhauls its research operations.
Medications
Mar 21, 2013 |
not rated yet |
0
97 percent of UK doctors have given placebos to patients at least once
A survey of UK doctors found that 97% have prescribed placebo treatments to patients at least once in their career.
Medications
Mar 20, 2013 |
not rated yet |
0
Malaria vaccine fails to work after four years
A new vaccine that has raised hopes of becoming a potent new tool in the battle against malaria seems to stop working in children after four years, according to research published Wednesday.
Medications
Mar 20, 2013 |
1 / 5 (1) |
0
FDA warns of another compounding pharmacy recall
(AP)—The Food and Drug Administration is warning doctors that a compounding pharmacy is recalling syringes of the Roche drug Avastin after receiving reports of eye infections among patients.
Medications
Mar 20, 2013 |
not rated yet |
0
Studies for approval of new drugs have insufficient patients to evaluate safety
For medicines intended for chronic use, the number of patients studied before regulatory approval is insufficient to properly evaluate safety and long-term efficacy, requiring the need for new legislation, according to a ...
Medications
Mar 19, 2013 |
not rated yet |
0
Court: Can generic drug maker be sued over design?
The Supreme Court will soon decide whether generic drug manufacturers can be sued in state court for a drug's design defects after federal officials approved the brand-name version.
Medications
Mar 19, 2013 |
not rated yet |
0
US warns of mold in recalled specialty drugs
The U.S. Food and Drug Administration warned doctors and hospital managers Monday about a nationwide recall of all drugs made by a New Jersey compounding pharmacy because of possible mold contamination.
Medications
Mar 18, 2013 |
not rated yet |
0
Millions of people in Asia potentially exposed to health risks of popular herbal medicines
Scientists from King's College London are warning that millions of people may be exposed to risk of developing kidney failure and bladder cancer by taking herbal medicines that are widely available in Asia. The medicines, ...
Medications
Mar 18, 2013 |
1 / 5 (1) |
0
AstraZeneca reorg to cut 1,600 jobs in US, UK
(AP)—Struggling Anglo-Swedish drugmaker AstraZeneca PLC said Monday that it will eliminate 1,600 jobs, mostly in the U.S. and United Kingdom, as its new CEO starts a major research and development reorganization.
Medications
Mar 18, 2013 |
not rated yet |
0
A combined approach needed to fight antibiotics resistance, research says
(Medical Xpress)—In her latest report to the government, Professor Dame Sally Davies - the UK's Chief Medical Officer - says the current antibiotics resistance crisis poses a "catastrophic threat". ...
Medications
Mar 15, 2013 |
4.5 / 5 (2) |
0
|
HPV vaccine trends point to failures in patient education, vaccine programs
Completion rates for the human papillomavirus (HPV) vaccine series across both genders continue to remain alarmingly low nearly seven years after its introduction, suggesting that better patient education and increased public ...
Medications
Mar 14, 2013 |
5 / 5 (1) |
0
US probes new pancreas risks with diabetes drugs (Update)
The U.S. Food and Drug Administration is looking into new evidence that suggests a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.
Medications
Mar 14, 2013 |
not rated yet |
0
FDA adds heart risk warning to popular antibiotic Zithromax
The Food and Drug Administration is warning doctors and patients that a widely used antibiotic from Pfizer can cause rare but deadly heart rhythms in some patients.
Medications
Mar 12, 2013 |
not rated yet |
0
Hard to find good info on drug safety in pregnancy
Nearly every woman takes a medication at some point during pregnancy. Yet there's disturbingly little easy-to-understand information about which drugs pose a risk to her baby, and what to do about it.
Medications
Mar 12, 2013 |
not rated yet |
0
FDA encourages opioid prescribers to pursue training
(HealthDay)—Prescribers of extended-release/long-acting (ER/LA) opioid analgesics are encouraged to participate in continuing medical education (CME) provided by manufacturers of these analgesics, according ...
Medications
Mar 12, 2013 |
not rated yet |
0
